Caris Life Sciences, Inc. (CAI)
25.63
-0.75
(-2.84%)
USD |
NASDAQ |
Aug 28, 16:00
25.59
-0.04
(-0.16%)
After-Hours: 05:36
Caris Life Sciences Total Long Term Debt (Quarterly) : 446.04M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 446.04M |
| March 31, 2026 | 425.12M |
| December 31, 2025 | 421.33M |
| September 30, 2025 | 420.29M |
| June 30, 2025 | 411.69M |
| Date | Value |
|---|---|
| March 31, 2025 | 413.80M |
| December 31, 2024 | 418.18M |
| September 30, 2024 | 0.00 |
| June 30, 2024 | 0.00 |
| March 31, 2024 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| CareDx, Inc. | 13.20M |
| Myriad Genetics, Inc. | 203.20M |
| BioRestorative Therapies, Inc. | 0.00 |
| Natera, Inc. | 143.07M |
| Exagen, Inc. | 26.68M |